Document is current
Any future updates will be listed below
-
Authors
Wuyts, Wim A
Lancaster, Lisa
Maher, Toby M https://orcid.org/0000-0001-7192-9149
Ryerson, Christopher J
Kreuter, Michael
Corte, Tamera J
Valenzuela, Claudia https://orcid.org/0000-0002-0856-6290
Barnes, Chris N
Lefebvre, Éric A
Cosgrove, Gregory P
Flaherty, Kevin R
Richeldi, Luca https://orcid.org/0000-0003-0506-9966
Cottin, Vincent
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct04396756 at ClinicalTrials.govnct06097260 at ClinicalTrials.govDocuments that mention this clinical trial
Bexotegrast for treatment of idiopathic pulmonary fibrosis (BEACON-IPF): study protocol for a multinational, phase 2b/3, double-blind, randomised, multicentre, controlled trial
https://doi.org/10.1136/bmjresp-2024-002937
nct06097260 at ClinicalTrials.govDocuments that mention this clinical trial
Bexotegrast for treatment of idiopathic pulmonary fibrosis (BEACON-IPF): study protocol for a multinational, phase 2b/3, double-blind, randomised, multicentre, controlled trial
https://doi.org/10.1136/bmjresp-2024-002937
nct05621252 at ClinicalTrials.govDocuments that mention this clinical trial
Bexotegrast for treatment of idiopathic pulmonary fibrosis (BEACON-IPF): study protocol for a multinational, phase 2b/3, double-blind, randomised, multicentre, controlled trial
https://doi.org/10.1136/bmjresp-2024-002937
nct04396756 at ClinicalTrials.govDocuments that mention this clinical trial
Bexotegrast for treatment of idiopathic pulmonary fibrosis (BEACON-IPF): study protocol for a multinational, phase 2b/3, double-blind, randomised, multicentre, controlled trial
https://doi.org/10.1136/bmjresp-2024-002937
Documents that mention this clinical trial
Bexotegrast for treatment of idiopathic pulmonary fibrosis (BEACON-IPF): study protocol for a multinational, phase 2b/3, double-blind, randomised, multicentre, controlled trial
https://doi.org/10.1136/bmjresp-2024-002937
-
Funding
Funding for this research was provided by:
Pliant Therapeutics, Inc. (N/A)
- License Information
